These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4968811)

  • 1. Biochemical determinants in the evaluation of monoamine-oxidase inhibitors.
    Gabay S; Valcourt AJ
    Recent Adv Biol Psychiatry; 1968; 10():29-41. PubMed ID: 4968811
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of inhibition of beef liver mitochondrial monoamine oxidase by iproniazid.
    Gomes B
    Indian J Biochem Biophys; 1983 Apr; 20(2):96-9. PubMed ID: 6671669
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of the mechanism of action of the new antidepressant pyrazidol].
    Mashkovskiĭ MD; Gorkin VZ; Andreeva NI; Verevkina IV; Siniukhin VN
    Farmakol Toksikol; 1975; 38(5):531-6. PubMed ID: 1183581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
    Fisar Z; Hroudová J; Raboch J
    Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of rabbit liver mitochondrial monoamine oxidase by new hydrazine derivatives. II. Probable prosthetic groups of the enzyme, and their blocking by the compound 31037-S or 31087-S.
    Kurosawa A
    Chem Pharm Bull (Tokyo); 1969 Jan; 17(1):43-8. PubMed ID: 5771629
    [No Abstract]   [Full Text] [Related]  

  • 6. Guanylhydrazones, another class of monoamine oxidase inhibitors.
    Mutschler E; Springer J; Wassermann O
    Biochem Pharmacol; 1970 Jan; 19(1):9-15. PubMed ID: 5507652
    [No Abstract]   [Full Text] [Related]  

  • 7. [Relation between the anti-inflammatory effect and inhibiting activity of monoaminoxidase inhibitors].
    Trinus FP; Riabukha TK
    Farmakol Toksikol; 1973; 36(1):84-9. PubMed ID: 4685161
    [No Abstract]   [Full Text] [Related]  

  • 8. Occurrence of newly synthesized monoamine oxidase in subcellular fractions of the rat liver.
    Erwin VG; Simon RJ
    J Pharm Sci; 1969 Aug; 58(8):1033-5. PubMed ID: 5344520
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of monoamine oxidase inhibitors of various chemical nature on some indices of carbohydrate metabolism in the rabbit brain].
    Musialkovskaia AA
    Ukr Biokhim Zh; 1967; 39(2):119-24. PubMed ID: 5603054
    [No Abstract]   [Full Text] [Related]  

  • 10. Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs.
    Neff NH; Yang HY
    Life Sci; 1974 Jun; 14(11):2061-74. PubMed ID: 4603266
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preliminary tests of the action of an MAO inhibitor (Iproniazid) on iris motility].
    Balacco-Gabrieli C
    Boll Soc Ital Biol Sper; 1971 Jan; 47(2):36-8. PubMed ID: 5088816
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of monoamine oxidase inhibitors on iris motility].
    Balacco-Gabrieli C; Scorcia G
    Minerva Oftalmol; 1971; 13(4):117-24. PubMed ID: 5145165
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of monoamine oxidase in the cardiac accumulation of norepinephrine.
    Lee WC; Yoo CS
    Arch Int Pharmacodyn Ther; 1967 Sep; 169(1):221-36. PubMed ID: 6055131
    [No Abstract]   [Full Text] [Related]  

  • 14. Action of inhibitors on monoamine and diamine metabolism in the rat.
    Sourkes TL; Missala K
    Can J Biochem; 1977 Jan; 55(1):56-9. PubMed ID: 402175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine oxidase and inhibitors.
    Goergen K
    Humangenetik; 1970; 9(3):205-6. PubMed ID: 5451683
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of monoamine oxidase activity in sympathetic ganglia of the cat.
    LEVINE RJ
    Biochem Pharmacol; 1962; 11():395-6. PubMed ID: 14464650
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis of some N-substituted eleostearic acid hydrazides as potential monoamine oxidase inhibitors.
    Hsu SY; Huang CL; Waters IW
    J Med Chem; 1973 May; 16(5):450-2. PubMed ID: 4146252
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of 4H-3-methylcarboxamide-1,3-benzoxazine-2-one (FI 6654) on monoaminoxidase and cerebral 5-HT.
    Suchowsky GK; Pegrassi L; Moretti A; Bonsignori A
    Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):332-40. PubMed ID: 5308944
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors.
    Ulus IH; Maher TJ; Wurtman RJ
    Biochem Pharmacol; 2000 Jun; 59(12):1611-21. PubMed ID: 10799660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.